Company Filing History:
Years Active: 2005
Title: **Enrique Gerardo Guillen Nieto: A Pioneer in Biotechnological Innovations**
Introduction
Enrique Gerardo Guillen Nieto is a notable inventor hailing from Habana, Cuba, recognized for his significant contributions in the field of biotechnology and genetic engineering. With a focus on innovative approaches to protein expression in microorganisms, his work has the potential to revolutionize vaccine development and disease prevention.
Latest Patents
Guillen Nieto holds a patent for his invention titled "Monoclonal antibody to the stabilizer peptide of the P64K antigen of Neisseria meningitidis." This innovative patent centers on expressing viral proteins in microorganisms by employing recombinant DNA technology. The process facilitates the generation of heterologous proteins as fusion peptides, allowing for high-purity yields suitable for inclusion in vaccine preparations. The invention specifically utilizes a stabilizing sequence derived from the first 47 amino acids of the P64K antigen, incorporating a recombinant plasmid that is controlled by the tryptophan promoter and transcription terminator of phage T4.
Career Highlights
Guillen Nieto's career has been marked by his affiliation with the Centro de Ingeniería Genética y Biotecnología, where he has worked on pioneering research in the realm of genetic engineering. His expertise in the field has had a profound impact on advancing biotechnological methods and therapeutics.
Collaborations
Throughout his career, Guillen Nieto has collaborated with esteemed colleagues, such as Carlos Antonio Durate Cano and Anabel Alvarez Acosta. These partnerships have fostered a collaborative atmosphere that encourages innovation and excellence in scientific research.
Conclusion
Enrique Gerardo Guillen Nieto exemplifies the spirit of innovation in biotechnology. Through his patent work and collaborations, he has made significant strides in the field, contributing to the development of novel solutions for vaccine preparation and disease management. His achievements serve as an inspiration for future generations of inventors and scientists in the realm of genetic engineering.